相关实验视频
Updated: Jul 24, 2025

06:06
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
5.3K
链延长的E3泛素酶UBR5的冷-EM结构
Zuzana Hodáková1, Irina Grishkovskaya1, Hanna L Brunner1,2
1Research Institute of Molecular Pathology (IMP), ViennaBioCenter (VBC), Vienna, Austria.
The EMBO journal
|July 6, 2023
概括
这项研究揭示了UBR5的结构,UBR5是一种涉及癌症的核E3结合酶. 这就是UBR5 UBR5的特性.
科学领域:
- 生物化学 生化学
- 结构生物学 结构生物学
- 分子生物学分子生物学
背景情况:
- UBR5是一种核E3结合酶,调节像MYC这样的瘤基因.
- 它的结构和基质参与机制不太清楚.
- 含有HECT域的泛素酶在细胞过程中起着至关重要的作用.
研究的目的:
- 为了确定人类UBR5.5的冷-EM结构.
- 为了研究UBR5的基质接触和无处不在机制.
- 描述UBR5的相互作用和酶活性.
主要方法:
- 电子显微镜 (cryo-EM) 用于结构的确定.
- 生物化学测试以表征酶活性.
- 识别相互作用的蛋白质.
主要成果:
- 冷-EM结构揭示了一个α-solenoid支架在一个反平行二元体,具有动态催化域.
- UBR5与蛋白质体核进口因子AKIRIN2相互作用.
- UBR5 作为一种高效的泛胺链延长剂,更喜欢泛胺基质.
结论:
- 这项研究提供了对人类UBR5的第一个结构洞察,UBR5是关键的E3结合酶.
- UBR5的结构及其作为全方位链延长者的作用为其参与各种信号通路和癌症提供了解释.
- 这项工作扩大了对HECT E3结合酶结构和功能的理解.
相关概念视频
Export of Misfolded Proteins out of the ER
3.7K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.7K
Regulation of the Unfolded Protein Response
2.5K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
Intralumenal Vesicles and Multivesicular Bodies
3.6K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.6K
The Proteasome Structure
809
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
809
The Unfolded Protein Response
4.8K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.8K
The Proteasome
907
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
907

